Structural prediction of the β-domain of metallothionein-3 by molecular dynamics simulation

Proteins: Structure, Function and Genetics

Volumn 68, Issue 1, 2007, Pages 255-266

  Ni, Feng Yun ^a   Cai, Bin ^a   Ding, Zhi Chun ^a   Zheng, Fei ^a   Zhang, Ming Jie ^b   Wu, Hou Ming ^c   Sun, Hong Zhe ^d   Huang, Zhong Xian ^a  

^a FUDAN UNIVERSITY   (China)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^c SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Folding; Force field; GIF; Metallothionein 3; TCPCP motif

Indexed keywords

METALLOTHIONEIN II; METALLOTHIONEIN III;

AMINO ACID SEQUENCE; ARTICLE; COMPUTER SIMULATION; CONFORMATIONAL TRANSITION; ENERGY TRANSFER; HUMAN; MOLECULAR DYNAMICS; MOLECULAR MODEL; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN MOTIF; RAT;

AMINO ACID MOTIFS; ANIMALS; BIOPHYSICS; CADMIUM; COMPUTER SIMULATION; MODELS, MOLECULAR; NERVE TISSUE PROTEINS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SULFUR;

EID: 34249912942     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21404     Document Type: Article

References (49)

1. Margoshes M, Vallee BL. A cadmium protein from equine kidney cortex. J Am Chem Soc 1957;79:4813-4814.
2. Kagi JHR, Vallee BL. Metallothoinein: a cadmium- and zinc-containing protein from equine renal cortex. J Biol Chem 1960;235:3460-3465.
3. Kagi JHR, Vallee BL. Metallothionein: a cadmium- and zinc-containing protein from equine renal cortex. II. Physicochemical properties J Biol Chem 1961;236:2435-2442.
4. Kagi JHR. Overview of metallothionein. Method Enzymol 1991;205:613-626.
5. Stillman MJ. Metallothioneins Coord Chem Rev 1995;144:461-511.
6. Romero-Isart N, Vasak M. Advances in the structure and chemistry of metallothioneins. J Inorg Biochem 2002;88:388-396.
7. Vasak M, Hasler DW, Faller P. Metal-thiolate clusters in neuronal growth inhibitory factor (GIF). J Inorg Biochem 2000;79:7-10.
8. Amiard JC, Amiard-Triquet C, Barka S, Pellerin J, Rainbow PS. Metallothioneins in aquatic invertebrates: their role in metal detoxification and their use as biomarkers. Aquat Toxicol 2006;76:160-202.
9. Cobbett C, Goldsbrough P. Phytochelatins and metallothioneins: roles in heavy metal detoxification and homeostasis. Annu Rev Plant Biol 2002;53:159-182.
10. Tapiero H, Tew KD. Trace elements in human physiology and pathology: zinc and metallothioneins. Biomed Pharmacother 2003;57:399-411.
11. Moffatt P, Denizeau F. Metallothionein in physiological and physiopathological processes. Drug Metab Rev 1997;29:261-307.
12. Uchida Y, Takio K, Titani K, Ihara Y, Tomonaga M. The growth inhibitory factor that is deficient in the alzheimers-disease brain is a 68-amino acid metallothionein-like protein. Neuron 1991;7:337-347.
13. Amoureux MC, Van Gool D, Herrero MT, Dom R, Colpaert FC, Pauwels PJ. Regulation of metallothionein-III (GIF) mRNA in the brain of patients with Alzheimer disease is not impaired. Mol Chem Neuropathol 1997;32:101-121.
14. Arai Y, Uchida Y, Takashima S. Developmental immunohistochemistry of growth inhibitory factor in normal brains and brains of patients with down syndrome. Pediatr Neurol 1997;17:134-138.
15. Erickson JC, Sewell AK, Jensen LT, Winge DR, Palmiter RD. Enhanced neurotrophic activity in alzheimers-disease cortex is not associated with down-regulation of metallothionein-Iii (Gif). Brain Res 1994;649:297-304.
16. Hidalgo J, Aschner M, Zatta P, Vasak M. Roles of the metallothionein family of proteins in the central nervous system. Brain Res Bull 2001;55:133-145.
17. Sewell AK, Jensen LT, Erickson JC, Palmiter RD, Winge DR. Bioactivity of metallothionein-3 correlates with its novel betadomain sequence rather than metal-binding properties. Biochemistry 1995;34:4740-4747.
18. Uchida Y, Ihara Y. The N-terminal portion of growth-inhibitory factor is sufficient for biological-activity. J Biol Chem 1995;270:3365-3369.
19. Hasler DW, Jensen LT, Zerbe O, Winge DR, Vasak M. Effect of the two conserved prolines of human growth inhibitory factor (metallothionein-3) on its biological activity and structure fluctuation: comparison with a mutant protein. Biochemistry 2000;39:14567-14575.
20. Romero-Isart N, Jensen LT, Zerbe O, Winge DR, Vasak M. Engineering of metallothionein-3 neuroinhibitory activity into the inactive isoform metallothionein-1. J Biol Chem 2002;277:37023-37028.
21. Robbins AH, McRee DE, Williamson M, Collett SA, Xuong NH, Furey WF, Wang BC, Stout CD. Refined crystal-structure of Cd, Zn metallothionein at 2.0 a resolution. J Mol Biol 1991;221:1269-1293.
22. Bogumil R, Faller P, Binz PA, Vasak M, Charnock JM, Garner CD. Structural characterization of Cu(I) and Zn(II) sites in neuronal-growth-inhibitory factor by extended X-ray absorption fine structure (EXAFS). Eur J Biochem 1998;255:172-177.
23. Messerle BA, Schaffer A, Vasak M, Kagi JH, Wuthrich K. Three-dimensional structure of human [113Cd7]metallothionein-2 in solution determined by nuclear magnetic resonance spectroscopy. J Mol Biol 1990;214:765-779.
24. Narula SS, Brouwer M, Hua Y, Armitage IM. Three-dimensional solution structure of Callinectes sapidus metallothionein-1 determined by homonuclear and heteronuclear magnetic resonance spectroscopy. Biochemistry 1995;34:620-631.
25. Schultze P, Worgotter E, Braun W, Wagner G, Vasak M, Kagi JH, Wuthrich K. Conformation of [Cd7]-metallothionein-2 from rat liver in aqueous solution determined by nuclear magnetic resonance spectroscopy. J Mol Biol 1988;203:251-268.
26. Zangger K, Oz G, Otvos JD, Armitage IM. Three-dimensional solution structure of mouse [Cd-7]-metallothionein-1 by homonuclear and heteronuclear NMR spectroscopy. Protein Sci 1999;8:2630-2638.
27. Oz G, Zangger K, Armitage IM. Three-dimensional structure and dynamics of a brain specific growth inhibitory factor: metallothionein-3. Biochemistry 2001;40:11433-11441.
28. Wang H, Zhang Q, Cai B, Li H, Sze KH, Huang ZX, Wu HM, Sun H. Solution structure and dynamics of human metallothionein-3 (MT-3). FEBS Lett 2006;580:795-800.
29. Chan J, Huang ZY, Merrifield ME, Salgado MT, Stillman MJ. Studies of metal binding reactions in metallothioneins by spectroscopic, molecular biology, and molecular modeling techniques. Coord Chem Rev 2002;233:319-339.
30. Maret W, Heffron G, Hill HA, Djuricic D, Jiang LJ, Vallee BL. The ATP/metallothionein interaction: NMR and STM. Biochemistry 2002;41:1689-1694.
31. Hansson T, Oostenbrink C, van Gunsteren WF. Molecular dynamics simulations. Curr Opin Struct Biol 2002;12:190-196.
32. Banci L. Molecular dynamics simulations of metalloproteins. Curr Opin Chem Biol 2003;7:143-149.
33. Berweger CD, Thiel W, van Gunsteren WF. Molecular-dynamics simulation of the beta domain of metallothionein with a semiempirical treatment of the metal core. Proteins 2000;41:299-315.
34. Fowle DA, Stillman MJ. Comparison of the structures of the metal-thiolate binding site in Zn(II)-, Cd(II)-, and Hg(II)-metallothioneins using molecular modeling techniques. J Biomol Struct Dyn 1997;14:393-406.
35. Rigby KE, Chan J, Mackie J, Stillman MJ. Molecular dynamics study on the folding and metallation of the individual domains of metallothionein. Proteins 2006;62:159-172.
36. Chan J, Merrifield ME, Soldatov AV, Stillman MJ. XAFS spectral analysis of the cadmium coordination geometry in cadmium thiolate clusters in metallothionein. Inorg Chem 2005;44:4923-4933.
37. Roschitzki B, Vasak M. Redox labile site in a Zn4 cluster of MT3. Biochemistry 2003;42:9822-9828.
38. Tsuji S, Kobayashi H, Uchida Y, Ihara Y, Miyatake T. Molecular-cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's-Disease. EMBO J 1992;11:4843.
39. MacKerell AD, Bashford D, Bellott M, Dunbrack RL, Evanseck JD, Field MJ, Fischer S, Gao J, Guo H, Ha S, Joseph-McCarthy D, Kuchnir L, Kuczera K, Lau FTK, Mattos C, Michnick S, Ngo T, Nguyen DT, Prodhom B, Reiher WE, Roux B, Schlenkrich M, Smith JC, Stote R, Straub J, Watanabe M, Wiorkiewicz-Kuczera J, Yin D, Karplus M. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 1998;102:3586-3616.
40. Mackerell AD, Feig M, Brooks CL. Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations. J Comput Chem 2004;25:1400-1415.
41. Bredenberg J, Nilsson L. Modeling zinc sulfhydryl bonds in zinc fingers. Int J Quantum Chem 2001;83:230-244.
42. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996;14:33-36.
43. Kale L, Skeel R, Bhandarkar M, Brunner R, Gursoy A, Krawetz N, Phillips J, Shinozaki A, Varadarajan K, Schulten K. NAMD2: greater scalability for parallel molecular dynamics. J Comput Phys 1999;151:283-312.
44. Braun W, Vasak M, Robbins AH, Stout CD, Wagner G, Kagi JH, Wuthrich K. Comparison of the NMR solution structure and the x-ray crystal structure of rat metallothionein-2. Proc Natl Acad Sci USA 1992;89:10124-10128.
45. Zheng Q, Yang WM, Yu WH, Cai B, Teng XC, Xie Y, Sun HZ, Zhang MJ, Huang ZX. The effect of the EAAEAE insert on the property of human metallothionein-3. Protein Eng 2003;16:865-870.
46. Zheng Q, Cai B, Chen D, Yu WH, Wang YH, Huang ZX. The reaction of metallothionein-3 with DTNB. Chem Lett 2003;32:616-617.
47. Cai B, Zheng Q, Teng XC, Chen D, Wang Y, Wang KQ, Zhou GM, Xie Y, Zhang MJ, Sun HZ, Huang ZX. The role of Thr5 in human neuron growth inhibitory factor. J Biol Inorg Chem 2006;11:476-482.
48. 2+. J Inorg Biochem 2002;88:144-152.
49. Rigby KE, Stillman MJ. Structural studies of metal-free metallothionein. Biochem Biophys Res Commun 2004;325:1271-1278.